Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

After years of potential, cell and gene therapy is ready for the pharmaceutical mainstream

Thanks to advances in technology and new commercial viability, cell and gene therapy is finally coming of age

- PMLiVE

Don’t let COVID-19 put the brakes on your career

One considerable upside of the COVID-19 crisis is the opportunity to reflect on our lives and what’s important to us. Our career choices have come into sharper focus as we...

Nucleus Global

- PMLiVE

J&J completes enrolment for late-stage COVID-19 vaccine trial

Company announces that around 45,000 participants have been enrolled

- PMLiVE

Amgen aims for first KRAS inhibitor approval in the US

Sotorasib is a potential treatment for advanced KRAS G12C-mutated NSCLC

- PMLiVE

GSK pays $85m upfront for Surface Oncology’s lead cancer drug

British pharma company adds preclinical antibody to its pipeline

- PMLiVE

Moderna scores FDA panel backing for mRNA-based COVID-19 vaccine

EMA also brings forward review meeting of vaccine

- PMLiVE

Chaperone Leadership

An insightful parallel between bosses and biology

- PMLiVE

‘Moving during a global pandemic was the best professional decision I could have made’

Below we hear from Helena Whelan about her experiences of moving jobs during a Global pandemic and why she chose to return to Nucleus Global.

Nucleus Global

- PMLiVE

Novartis receives FDA breakthrough therapy designation for rare disease med

The Swiss pharma company is eyeing approval in PNH and C3G indications

Patient Partnerships: Challenges and Opportunities for Pharma

Durhane Wong-Rieger, President & CEO of the Canadian Organization for Rare Disorders, joins Natalie Yeadon, Co-owner & Managing Director at Impetus Digital, for this live Fireside Chat. Today, we are exploring...

Impetus Digital

Top 10 Tips for Creating Company Culture in a Virtual World

Remote work is here to stay. Learn how companies and employees can thrive in this new environment

Impetus Digital

- PMLiVE

Lilly picks up gene therapy programme in $1bn Prevail Therapeutics acquisition deal

Acquisition includes a number of candidates for neurodegenerative diseases

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links